Schwann cells act as central repair components of many nerve pathologies.
Trans-differentiation is necessary for their conversion to repair mediating cells.
Fingolimod promotes the generation of a repair associated Schwann cell phenotype.
Fingolimod enhances the axon regeneration promoting potential of Schwann cells.
Fingolimod could therefore be used for future nerve repair therapies.